Novel Associations of Dyslipidaemia with Vitamin D and Bone Metabolism in Elderly Patients with Diabetes: A Cross-Sectional Study

References

• Raggi P. Screening for atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus: controversies and guidelines. Can J Diabetes. 2020;44(1):86–92. doi:10.1016/j.jcjd.2019.08.009
   PubMed Web of Science ®Google Scholar
• Walsh JS, Vilaca T. Obesity, type 2 diabetes and bone in adults. Calcif Tissue Int. 2017;100(5):528–535. doi:10.1007/s00223-016-0229-0
   PubMed Web of Science ®Google Scholar
• Farhat GN, Cauley JA, Matthews KA, et al. Volumetric BMD and vascular calcification in middle-aged women: the study of women’s health across the nation. J Bone Miner Res. 2006;21(12):1839–1846. doi:10.1359/jbmr.060903
   PubMed Web of Science ®Google Scholar
• Tankò LB, Bagger YZ, Christiansen C. Low bone mineral density in the Hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int. 2003;73(1):15–20. doi:10.1007/s00223-002-2070-x
   PubMed Web of Science ®Google Scholar
• Tankó LB, Christiansen C, Cox DA, et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res. 2005;20(11):1912–1920. doi:10.1359/jbmr.050711
   PubMed Web of Science ®Google Scholar
• Bahiru E, Hsiao R, Phillipson D, Watson KE. Mechanisms and treatment of dyslipidemia in diabetes. Curr Cardiol Rep. 2021;23(4):26. doi:10.1007/s11886-021-01455-w
   PubMed Web of Science ®Google Scholar
• Kaze AD, Santhanam P, Musani SK, Ahima R, Echouffo-Tcheugui JB. Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: findings from the look AHEAD study. J Am Heart Assoc. 2021;10(7):e016947. doi:10.1161/jaha.120.016947
   PubMed Web of Science ®Google Scholar
• Cai F, Yusufu A, Liu K, et al. High-fat diet causes undesirable bone regeneration by altering the bone marrow environment in rats. Front Endocrinol. 2023;14:1088508. doi:10.3389/fendo.2023.1088508
   PubMed Web of Science ®Google Scholar
• van Driel M, Van Leeuwen J. Vitamin D and bone: a story of endocrine and auto/paracrine action in osteoblasts. Nutrients. 2023;15(3):480. doi:10.3390/nu15030480
   PubMed Web of Science ®Google Scholar
• Lips P, Eekhoff M, van Schoor N, et al. Vitamin D and type 2 diabetes. J Steroid Biochem Mol Biol. 2017;173:280–285. doi:10.1016/j.jsbmb.2016.11.021
   PubMed Web of Science ®Google Scholar
• Sacerdote A, Dave P, Lokshin V, Bahtiyar G. Type 2 diabetes mellitus, insulin resistance, and vitamin D. Curr Diab Rep. 2019;19(10):101. doi:10.1007/s11892-019-1201-y
   PubMed Web of Science ®Google Scholar
• Yu JR, Lee SA, Lee JG, et al. Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus. Chonnam Med J. 2012;48(2):108–115. doi:10.4068/cmj.2012.48.2.108
   PubMedGoogle Scholar
• Zhu T, Zhao J, Zhuo S, et al. High fat diet and high cholesterol diet reduce hepatic vitamin D-25-hydroxylase expression and serum 25-hydroxyvitamin D(3) level through elevating circulating cholesterol, glucose, and insulin levels. Mol Nutr Food Res. 2021;65(21):e2100220. doi:10.1002/mnfr.202100220
   PubMed Web of Science ®Google Scholar
• Wu LY, Yang TC, Kuo SW, et al. Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res. 2003;29(3):317–325. doi:10.1081/erc-120025039
   PubMed Web of Science ®Google Scholar
• Wan H, Wang Y, Zhang K, et al. Associations between Vitamin D and microvascular complications in middle-aged and elderly diabetic patients. Endocr Pract. 2019;25(8):809–816. doi:10.4158/ep-2019-0015
   PubMed Web of Science ®Google Scholar
• Wang N, Wang X, Li Q, et al. The famine exposure in early life and metabolic syndrome in adulthood. Clin Nutr. 2017;36(1):253–259. doi:10.1016/j.clnu.2015.11.010
   PubMed Web of Science ®Google Scholar
• Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555–562. doi:10.1038/ki.2010.462
   PubMed Web of Science ®Google Scholar
• Liu X, Yu S, Mao Z, et al. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study. Lipids Health Dis. 2018;17(1):119. doi:10.1186/s12944-018-0768-7
   PubMedGoogle Scholar
• Russo G, Pintaudi B, Giorda C, et al. Age- and gender-related differences in LDL-cholesterol management in outpatients with type 2 diabetes mellitus. Int J Endocrinol. 2015;2015:957105. doi:10.1155/2015/957105
   PubMed Web of Science ®Google Scholar
• Wang X, Magkos F, Mittendorfer B. Sex differences in lipid and lipoprotein metabolism: it’s not just about sex hormones. J Clin Endocrinol Metab. 2011;96(4):885–893. doi:10.1210/jc.2010-2061
   PubMed Web of Science ®Google Scholar
• Link JC, Reue K. Genetic basis for sex differences in obesity and lipid metabolism. Annu Rev Nutr. 2017;37:225–245. doi:10.1146/annurev-nutr-071816-064827
   PubMed Web of Science ®Google Scholar
• Baars A, Oosting A, Lohuis M, et al. Sex differences in lipid metabolism are affected by presence of the gut microbiota. Sci Rep. 2018;8(1):13426. doi:10.1038/s41598-018-31695-w
   PubMedGoogle Scholar
• Lupton JR, Faridi KF, Martin SS, et al. Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: the Very Large Database of Lipids (VLDL-3) study. J Clin Lipidol. 2016;10(1):72–81.e71. doi:10.1016/j.jacl.2015.09.006
   PubMed Web of Science ®Google Scholar
• Bahadorpour S, Hajhashemy Z, Saneei P. Serum 25-hydroxyvitamin D levels and dyslipidemia: a systematic review and dose-response meta-analysis of epidemiologic studies. Nutr Rev. 2022;81:1–25. doi:10.1093/nutrit/nuac038
   PubMed Web of Science ®Google Scholar
• Yavuz B, Ertugrul DT, Cil H, et al. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther. 2009;23(4):295–299. doi:10.1007/s10557-009-6181-8
   PubMed Web of Science ®Google Scholar
• Kuchuk NO, Pluijm SM, van Schoor NM, et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009;94(4):1244–1250. doi:10.1210/jc.2008-1832
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu G, Zhang Y, et al. Association between bone mineral density, bone turnover markers, and serum cholesterol levels in type 2 diabetes. Front Endocrinol. 2018;9:646. doi:10.3389/fendo.2018.00646
   PubMed Web of Science ®Google Scholar
• Makovey J, Chen JS, Hayward C, Williams FM, Sambrook PN. Association between serum cholesterol and bone mineral density. Bone. 2009;44(2):208–213. doi:10.1016/j.bone.2008.09.020
   PubMed Web of Science ®Google Scholar
• Cui LH, Shin MH, Chung EK, et al. Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea. Osteoporos Int. 2005;16(12):1975–1981. doi:10.1007/s00198-005-1977-2
   PubMed Web of Science ®Google Scholar
• Martins JM, Aranha P. Bone turnover and bone mineral density in old persons with type 2 diabetes. J Clin Transl Endocrinol. 2018;14:12–18. doi:10.1016/j.jcte.2018.09.002
   PubMedGoogle Scholar
• Majima T, Shimatsu A, Komatsu Y, et al. Increased bone turnover in patients with hypercholesterolemia. Endocr J. 2008;55(1):143–151. doi:10.1507/endocrj.k07e-004
   PubMed Web of Science ®Google Scholar
• Zhou Y, Deng T, Zhang H, et al. Hypercholesterolaemia increases the risk of high‑turnover osteoporosis in men. Mol Med Rep. 2019;19(6):4603–4612. doi:10.3892/mmr.2019.10131
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Yamaguchi T, Nawata K, et al. Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women. Endocrine. 2015;48(1):279–286. doi:10.1007/s12020-014-0292-0
   PubMed Web of Science ®Google Scholar
• Li W, Liu X, Liu L, et al. Relationships of serum bone turnover markers with metabolic syndrome components and carotid atherosclerosis in patients with type 2 diabetes mellitus. Front Cardiovasc Med. 2022;9:824561. doi:10.3389/fcvm.2022.824561
   PubMed Web of Science ®Google Scholar
• Liu XX, Jiang L, Liu Q, et al. Low bone turnover markers in young and middle-aged male patients with type 2 diabetes mellitus. J Diabetes Res. 2020;2020:6191468. doi:10.1155/2020/6191468
   PubMed Web of Science ®Google Scholar
• Laurent MR, Cook MJ, Gielen E, et al. Lower bone turnover and relative bone deficits in men with metabolic syndrome: a matter of insulin sensitivity? The European Male Ageing Study. Osteoporos Int. 2016;27(11):3227–3237. doi:10.1007/s00198-016-3656-x
   PubMed Web of Science ®Google Scholar
• Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL. Mechanisms in Endocrinology: diabetes mellitus, a state of low bone turnover - A systematic review and meta-analysis. Eur J Endocrinol. 2017;176(3):R137–r157. doi:10.1530/eje-16-0652
   PubMed Web of Science ®Google Scholar
• Zha KX, An ZM, Ge SH, et al. FSH may mediate the association between HbA1c and bone turnover markers in postmenopausal women with type 2 diabetes. J Bone Miner Metab. 2022;40(3):468–477. doi:10.1007/s00774-021-01301-7
   PubMed Web of Science ®Google Scholar
• Haffner SM. Dyslipidemia management in adults with diabetes. Diabetes Care. 2004;27(Suppl 1):S68–71. doi:10.2337/diacare.27.2007.s68
   PubMedGoogle Scholar
• Guo H, Wang C, Jiang B, et al. Association of insulin resistance and β-cell function with bone turnover biomarkers in dysglycemia patients. Front Endocrinol. 2021;12:554604. doi:10.3389/fendo.2021.554604
   PubMed Web of Science ®Google Scholar
• Li N, Fu J, Koonen DP, et al. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis. 2014;233(1):130–138. doi:10.1016/j.atherosclerosis.2013.12.013
   PubMed Web of Science ®Google Scholar